Belano medical skincare products see increased interest in 2021

For its research activities, Belano medical received a grant commitment by the State of Brandenburg

During the first half of 2021, Belano medical says it has consolidated its position as a developer and manufacturer of probiotic and microbiotic ingredients, both in Germany and internationally. The biotechnology company reportedly enjoyed strong growth in the market for cosmetic and medical skincare. Since the beginning of the year, cooperation agreements entered with the German Müller chain of retail stores and the Austrian Bipa chain of drugstores have boosted sales of medical skincare.

The company also delivered greater volumes of its microbiotic ingredient, in particular to businesses in the pharmaceutical industries which use it for skincare or other care products, or sell ready-delivered formulations under their brand. During the first half of the current business year, collaborations were entered with Henkel as well as the Dutch company AixSwiss, which produces the "nupure probaderm" skincare. In these collaborations and international sales, Belano's patented active ingredient based on a strain of natural lactic acid bacteria, plays a key role.

"The past two business quarters were a great success for Belano medical", said CEO Dr Bernd Wegener. "In a growing biotechnology market, we succeeded in gaining a position at the very top, in particular with regard to biologically based dermatology. Both our cooperation partners and the biotechnology market as such hold our scientific expertise and the practical relevance of our research and product development in high esteem."

Baby Hydro Gel, which the company developed and marketed, entered the market at the beginning of the year, and three months ago was picked from the product portfolios of more than 500 exhibitors at the B2B beauty and cosmetics fair to be listed as one of the best developments. The company currently offers a dozen own brand products in the area of dermatology or medical skincare.

In recent years, market demand for probiotic products and research results has skyrocketed. Prof Dr Christine Lang, CSO at Belano medical and Professor of Microbiology at the Technical University (TU) Berlin said: "In recent years, we’ve made considerable progress in researching the microbiome and its significance for human health. At the same time, however, a greater area remains unexplored, and it is here that there is enormous untapped potential for more care and medical products which are completely natural and probiotic."

Researching the microbiome also had great significance beyond the subject of health. "There's a huge number of industrial and social processes which have traditionally relied on fossil inputs, we gradually intend to reorganises these and turn them into a natural circular economy based on biomass, this is a global project", said Lang.

For its research activities, Belano medical received a grant commitment by the State of Brandenburg. These funds are intended for future research and development, as well as the expansion of national and international sales.

Companies